Millennium Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.05M | Sell |
32,600
-75,200
| -70% | -$5.24M | ﹤0.01% | 3855 |
|
|
2025
Q4 | $7.15M | Sell |
107,800
-84,500
| -44% | -$5.46M | ﹤0.01% | 2632 |
|
|
2025
Q3 | $12.9M | Buy |
192,300
+121,500
| +172% | +$9.62M | 0.01% | 2121 |
|
|
2025
Q2 | $6.18M | Sell |
70,800
-261,300
| -79% | -$20.5M | ﹤0.01% | 2774 |
|
|
2025
Q1 | $22.7M | Sell |
332,100
-320,400
| -49% | -$26.1M | 0.01% | 1393 |
|
|
2024
Q4 | $50.7M | Buy |
652,500
+434,500
| +199% | +$32.2M | 0.02% | 774 |
|
|
2024
Q3 | $14.6M | Buy |
218,000
+52,600
| +32% | +$4.32M | 0.01% | 1850 |
|
|
2024
Q2 | $18.8M | Buy |
165,400
+120,500
| +268% | +$15.2M | 0.01% | 1559 |
|
|
2024
Q1 | $6.23M | Sell |
44,900
-2,900
| -6% | -$365K | ﹤0.01% | 2656 |
|
|
2023
Q4 | $5.93M | Sell |
47,800
-309,500
| -87% | -$31.6M | ﹤0.01% | 2644 |
|
|
2023
Q3 | $33.3M | Buy |
357,300
+229,500
| +180% | +$25.9M | 0.02% | 1009 |
|
|
2023
Q2 | $16.4M | Buy |
127,800
+48,200
| +61% | +$5.83M | 0.01% | 1568 |
|
|
2023
Q1 | $9.25M | Sell |
79,600
-212,600
| -73% | -$23.8M | 0.01% | 2040 |
|
|
2022
Q4 | $33.1M | Buy |
292,200
+227,000
| +348% | +$24.9M | 0.02% | 1055 |
|
|
2022
Q3 | $5.25M | Sell |
65,200
-19,800
| -23% | -$1.68M | ﹤0.01% | 2846 |
|
|
2022
Q2 | $6.33M | Sell |
85,000
-91,400
| -52% | -$8.34M | ﹤0.01% | 2549 |
|
|
2022
Q1 | $22.6M | Buy |
176,400
+164,800
| +1,421% | +$18M | 0.01% | 1268 |
|
|
2021
Q4 | $1.56M | Sell |
11,600
-108,400
| -90% | -$15.6M | ﹤0.01% | 3996 |
|
|
2021
Q3 | $16.4M | Sell |
120,000
-134,000
| -53% | -$16.9M | 0.01% | 1515 |
|
|
2021
Q2 | $27.1M | Buy |
254,000
+194,000
| +323% | +$18.6M | 0.02% | 961 |
|
|
2021
Q1 | $5.39M | Buy |
60,000
+43,200
| +257% | +$4.06M | ﹤0.01% | 2487 |
|
|
2020
Q4 | $1.55M | Buy |
16,800
+10,000
| +147% | +$893K | ﹤0.01% | 3430 |
|
|
2020
Q3 | $701 | Sell |
6,800
-1,200
| -15% | -$125K | ﹤0.01% | 3377 |
|
|
2020
Q2 | $811K | Buy |
+8,000
| New | +$716K | ﹤0.01% | 3109 |
|
|
2020
Q1 | – | Sell |
-120,000
| Closed | -$6.56M | – | 3989 |
|
|
2019
Q4 | $6.56M | Sell |
120,000
-220,000
| -65% | -$10.4M | 0.01% | 1703 |
|
|
2019
Q3 | $12.7M | Buy |
340,000
+292,000
| +608% | +$11.3M | 0.02% | 1112 |
|
|
2019
Q2 | $1.8M | Sell |
48,000
-312,000
| -87% | -$9.81M | ﹤0.01% | 2465 |
|
|
2019
Q1 | $10.7M | Buy |
360,000
+280,000
| +350% | +$9.84M | 0.02% | 1195 |
|
|
2018
Q4 | $2.4M | Sell |
80,000
-120,000
| -60% | -$3.81M | ﹤0.01% | 2087 |
|
|
2018
Q3 | $7.15M | Sell |
200,000
-100,000
| -33% | -$3.1M | 0.01% | 1548 |
|
|
2018
Q2 | $7.12M | Sell |
300,000
-360,000
| -55% | -$7.63M | 0.01% | 1545 |
|
|
2018
Q1 | $12.2M | Buy |
660,000
+20,000
| +3% | +$296K | 0.02% | 1199 |
|
|
2017
Q4 | $9.18M | Buy |
640,000
+440,000
| +220% | +$5.72M | 0.01% | 1384 |
|
|
2017
Q3 | $2.45M | Buy |
+200,000
| New | +$3.54M | ﹤0.01% | 2061 |
|
|
2017
Q1 | – | Sell |
-500,000
| Closed | -$7.46M | – | 3554 |
|
|
2016
Q4 | $7.46M | Buy |
+500,000
| New | +$8.86M | 0.02% | 1086 |
|
|
2016
Q3 | – | Sell |
-40,000
| Closed | -$793K | – | 3321 |
|
|
2016
Q2 | $793K | Buy |
+40,000
| New | +$681K | ﹤0.01% | 2269 |
|
Other funds holding DXCM
VCM
VPM
Millennium Management's DXCM Position: Q1 2026 in Review
Millennium Management increased its DexCom (DXCM) stake by 2% in Q1 2026, buying an estimated $2.25M and bringing the position to 1,622,204 shares worth $102M. The position accounts for 0.04% of the portfolio, ranked #436.
Millennium Management first reported a position in DXCM in Q2 2013 and has held it in 50 quarters since. The position peaked at $441M in Q4 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Millennium Management held 1,622,204 shares of DexCom worth $102M as of Q1 2026.
- Millennium Management bought 32,327 DexCom shares in Q1 2026, an estimated $2.25M.
- DexCom made up 0.04% of Millennium Management's portfolio in Q1 2026, its #436 holding.
- Millennium Management first reported a position in DexCom in Q2 2013 and has held it in 50 quarters since.
- Millennium Management's DexCom position peaked at $441M in Q4 2022.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.